Untreated Sleep Apnea Risks: Why the Numbers Matter

Obstructive sleep apnea (OSA) is easy to dismiss as a snoring problem or a reason you feel groggy at breakfast. But the reason clinicians push so hard for diagnosis and consistent treatment is what happens beneath the poor sleep — the repeated drops in oxygen and the stress they place on your heart, blood vessels, and metabolism night after night. This guide walks through what untreated OSA is actually linked to, why the numbers on your therapy report matter, and how to turn that data into a productive conversation with your doctor.

Why untreated OSA is more than poor sleep

In obstructive sleep apnea, the upper airway repeatedly narrows or collapses during sleep. Each event ends with a brief drop in blood oxygen (intermittent hypoxia) and a micro-awakening you usually never remember. Multiply that by dozens or hundreds of times a night, for years, and the effects reach well beyond feeling tired.

Researchers point to a few core biological mechanisms that connect those nightly events to long-term harm:

• Intermittent hypoxia — repeated oxygen dips and recoveries that stress tissues and blood vessels.
• Oxidative stress and inflammation — by-products of those repeated stress cycles that can damage the vascular lining over time.
• Sympathetic surges — bursts of "fight-or-flight" nervous system activity at the end of each event that spike heart rate and blood pressure, even while you sleep.

This is why the consequences of untreated OSA are framed in terms of risk, not just symptoms. Untreated OSA is associated with lower quality of life and a higher risk of cardiovascular disease, stroke, and death. The encouraging flip side: these are precisely the outcomes that consistent, effective therapy is meant to help reduce — which is why confirming your treatment actually works matters so much.

If you're still learning the basics, our Understanding Sleep Apnea pillar and the primer What Is Sleep Apnea? lay the groundwork for everything below.

Cardiovascular and metabolic links

The strongest body of evidence ties OSA to the cardiovascular system. OSA is strongly associated with — and in several cases an independent risk factor for — a range of heart and vascular conditions, and is also linked to a major metabolic one.

Because these links are real, professional bodies recommend actively looking for OSA in certain higher-risk patients. The 2021 American Heart Association Scientific Statement (Yeghiazarians et al., Circulation) recommends OSA screening or testing in patients with:

• Resistant or poorly controlled high blood pressure
• Pulmonary hypertension
• Recurrent atrial fibrillation after cardioversion or ablation

The metabolic link deserves its own note. Type 2 diabetes is a cardiometabolic association supported by separate cohort literature rather than the cardiovascular statement above, and whether the link is fully independent of obesity is still debated. What the data does suggest is additive risk: observational cohort studies indicate that coexisting OSA and type 2 diabetes is associated with a greater (cumulative) risk of adverse cardiovascular outcomes and all-cause mortality than either condition alone. Keep in mind this is observational and "cumulative" — it describes risk that stacks, not a proven synergistic mechanism.

For a deeper look at the heart connection specifically, see Sleep Apnea and Your Heart: Hypertension, AFib, Stroke & Diabetes.

Quality of life and daytime safety

Risk isn't only a long-horizon concern. Untreated OSA lowers day-to-day quality of life in ways people often normalize after living with them for years:

• Excessive daytime sleepiness that no amount of coffee fully fixes
• Trouble concentrating, memory lapses, and low mood
• Morning headaches and unrefreshing sleep despite "enough" hours in bed
• Reduced exercise tolerance and libido

The safety dimension is the one that's easy to underrate. Sleepiness behind the wheel or on the job raises accident risk — a daytime consequence of a nighttime disorder. If you recognize these patterns and haven't been evaluated yet, Sleep Apnea Symptoms and When to See a Doctor About Snoring are good next reads. Curious whether you're predisposed? Who Gets Sleep Apnea? Risk Factors covers what you can and can't change.

Why adherence and effectiveness both matter

Here's the part many people miss: getting a CPAP isn't the finish line. Lowering your risk depends on therapy that is both adhered to (you use it consistently) and effective (it actually controls your events when you do). A machine worn faithfully but tuned poorly — or worn briefly but well — leaves risk on the table.

What "effective" actually means

The core number is your residual AHI — the apnea-hypopnea index measured while on therapy, i.e., how many events per hour still slip through.

• A residual AHI below 5 events per hour is the widely used benchmark for effective CPAP therapy. The American Academy of Sleep Medicine (AASM) defines an "optimal" titration as reducing the AHI to fewer than 5, and below 5 is also the normal, non-apneic range.
• Some clinicians aim lower (for example, under 1–2) when it's comfortably achievable, but there is no formal guideline establishing "below 2" as a target. Goals are individualized — your provider sets yours based on your symptoms and severity.

A couple of nuances worth knowing so your numbers don't mislead you:

• Device-reported AHI is an estimate. Your machine has no EEG and can't see arousals, so its AHI differs from lab-scored AHI. Hypopneas also depend on scoring rules — AASM Rule 1A (recommended: a 3% oxygen desaturation or an arousal) versus Rule 1B (acceptable/CMS: a 4% desaturation) can change the count. See What Is a Good AHI on CPAP? and How to Read Your CPAP Data for the full picture.
• Large leaks invalidate your numbers. If air is escaping past your mask, the machine can under-detect events and under-report your AHI — a low number can be a false comfort. For ResMed, the leak threshold is 24 L/min of excess leak at the 95th percentile (note ResMed reports excess leak while Philips reports total leak — different baselines). CPAP Leak Rate: What's Acceptable explains how to check yours.
• Rising central events (clear-airway apneas) are a different signal. CPAP reliably treats obstructive events but does not directly correct the unstable breathing drive behind central ones. A rise in central events on CPAP can indicate treatment-emergent central sleep apnea (TECSA, or "complex" sleep apnea), which appears in roughly 5–15% of titrations and resolves on its own in about 60–80% of cases within weeks to a few months of continued therapy. The right move is clinician evaluation if it persists — never raising pressure on your own to chase centrals, which doesn't fix them and can sometimes provoke them. More in Central Apneas Showing Up on CPAP.

Single nights are noise; trends are the signal

One bad night doesn't mean your therapy is failing, and one perfect night doesn't prove it's dialed in. AHI varies night to night for ordinary reasons — alcohol, congestion, sleeping position, allergies. What matters is the trend over weeks: is your AHI consistently controlled, are leaks staying in range, are central events stable or fading?

This is exactly where built-in apps fall short. ResMed's myAir, for instance, is ResMed-only and produces a 0–100 score weighted heavily toward usage hours — it can show 100 even at an AHI of 4.9, and it doesn't break out event types, leak detail, or flow limitation (and the formula has never been published). DreamMapper shut down in January 2026. And Philips DreamStation 2 SD-card data is encrypted, so OSCAR and most third-party tools can't read it at all.

That gap is the reason SomniCharts exists: it imports ResMed, Philips Respironics (including the encrypted DreamStation 2), and Löwenstein prisma data, then explains it in plain language automatically — tracking both your adherence and your effectiveness over time so you can confirm your CPAP is genuinely working, not just running. Because the cardiovascular and metabolic risks above hinge on effective therapy, watching those trends is the practical way to protect the gains treatment is meant to deliver. If you're comparing tools, OSCAR vs SleepHQ vs SomniCharts shows which platform reads which machine.

Talk to your doctor

The point of understanding these risks isn't to alarm you — it's to help you act on them with the right partner. Your therapy data is most powerful as a conversation-starter, not a substitute for clinical judgment.

A few practical steps:

1. If you suspect untreated OSA, get evaluated. Per the AASM Clinical Practice Guideline (Kapur et al., 2017), a home sleep apnea test (HSAT) can diagnose OSA in uncomplicated adults who show signs of an increased risk of moderate-to-severe OSA. In-lab polysomnography (PSG) is recommended instead for people with significant cardiorespiratory disease, possible respiratory muscle weakness from a neuromuscular condition, suspected hypoventilation, chronic opioid use, a history of stroke, or severe insomnia — and PSG is required to diagnose central sleep apnea or hypoventilation. If an HSAT is negative or inconclusive, a PSG should follow. See In-Lab PSG vs Home Test.
2. If you're already on CPAP, bring your trends — AHI, leak rate, 95th-percentile pressure, and any rising central events — to your next appointment. Use your data to have an informed conversation; don't self-adjust prescribed pressure or change settings on your own.
3. Flag returning symptoms. New daytime sleepiness, deeper oxygen drops, new medications, or new heart or kidney conditions are all reasons to check in sooner rather than later.

Treated well and monitored consistently, sleep apnea is a manageable condition. The numbers matter because they're the clearest early signal of whether your therapy is doing its job — and that's a question worth answering before the risks above have a chance to compound.